Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...

Reports Q4 revenue $4.56B, consensus $4.42B. “2024 was one of the best years in the history of Boston Scientific (BSX), fueled by our ...

The company said, “The company estimates net sales growth for the full year 2025, versus the prior year period, to be in a range of approximately 12.5 to 14.5 percent on a reported basis, and ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Just because it’s winter in Boston doesn’t mean you need to hibernate and stay indoors until spring arrives. From new stage shows to pop music concerts and everything in between, there are ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

TOKYO -- A disreputable scientific journal used generative AI to create bogus papers, using the names of three Japanese researchers without permission in what is thought to be an instance of ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + CEO Mike Mahoney expects more growth for the company in 2025.